News for 'Reliance Life Sciences'

Is Rahul Dividing India To Rule?

Is Rahul Dividing India To Rule?

Rediff.com3 Jul 2024

Is it is necessary to play divisive politics to succeed in the next general elections? asks Dr Sudhir Bisht.

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.

Modi @ Reliance hospital opening: 'Plastic surgeon may have fixed elephant's head on Ganesha'

Modi @ Reliance hospital opening: 'Plastic surgeon may have fixed elephant's head on Ganesha'

Rediff.com25 Oct 2014

Describing neonatal and maternal mortality rates as a matter of grave concern, Prime Minister Narendra Modi on Saturday said his government wanted to effectively use its 'Make in India' and 'Digital India' campaigns to reach healthcare to the country's poorest of the poor.

ASK AJIT: Advice For Long Term Investors

ASK AJIT: Advice For Long Term Investors

Rediff.com20 Jan 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

The TOP job trends in India

The TOP job trends in India

Rediff.com16 Jun 2021

Hiring for management professionals with greater than 16 years of experience witnessed a spike of 66% compared to last year.

ASK AJIT: Stocks to Buy, Hold, Sell

ASK AJIT: Stocks to Buy, Hold, Sell

Rediff.com28 Jan 2022

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

'You will succeed as long as you remember that the project is bigger than you'

'You will succeed as long as you remember that the project is bigger than you'

Rediff.com30 Aug 2023

'When a Project Director is appointed, the whole organization -- including the Chairman ISRO -- works for his success. It is a lesson that has been of abiding value all through the other projects I have worked on,' recalls the late President, one of the earliest pioneers at ISRO.

Ambani says will provide tech for COVID-19 vaccination drive

Ambani says will provide tech for COVID-19 vaccination drive

Rediff.com15 Dec 2020

As India gets ready to roll out one of the largest vaccine programmes, billionaire Mukesh Ambani on Tuesday said his group is working with authorities to provide technology tools and backbone for mass inoculation against COVID-19. Ambani's telecom venture Jio was rolled out four years back, offering free voice calling and dirt-cheap data. Today, Jio is India's largest telecom operator with over 400 million users, each connected to the internet. At a Facebook event, Ambani said the government's digital push kept the country running even during the pandemic and is now helping in the rollout of one of the largest vaccination programmes.

Which sectors to invest in? Read what experts say

Which sectors to invest in? Read what experts say

Rediff.com16 Sep 2022

After a turnaround in performance by Indian equity markets since July that has seen the S&P BSE Sensex and the Nifty50 wipe out the year-to-date losses, analysts suggest investors start nibbling into stocks that are focused on the domestic economy. While they say intermittent corrections, led by policies of global central banks and other economic data, cannot be ruled out, analysts expect India's relative outperformance among global equity markets to continue as it looks better placed with a healthy economic recovery, and remains one of the fastest growing major economies. In this backdrop, Neeraj Chadawar, head of quantitative equity strategy at Axis Securities, believes that amid global slowdown, aggressive tightening by the central banks, and preference for domestic interests first (by the local government), export-oriented themes are likely to be muted or will deliver conservative returns in the near-term.

NSE revises circuit limits of over 1,400 scrips

NSE revises circuit limits of over 1,400 scrips

Rediff.com7 Nov 2013

This measure will ensure that the price of a scrip cannot move upward or downward beyond a limit set for the day.

INCREDIBLE! How I lost 21 kg in 1.5 years

INCREDIBLE! How I lost 21 kg in 1.5 years

Rediff.com21 May 2020

Garima Bharucha, 39, from Mumbai shares her inspiring fitness journey and the lessons she learned along the way.

Brightest times ahead for women's cricket: Nita Ambani

Brightest times ahead for women's cricket: Nita Ambani

Rediff.com10 Nov 2020

Ambani then shed light on what a sport needs to grow. She said a holistic ecosystem needs to be developed around it and opportunities should be presented at the highest level.

Ask Ajit: 'Want to invest Rs 2 lakhs, please advise'

Ask Ajit: 'Want to invest Rs 2 lakhs, please advise'

Rediff.com22 Nov 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

10 firms that are likely to turnaround in FY15

10 firms that are likely to turnaround in FY15

Rediff.com23 Apr 2014

In the capital goods space, Punj Lloyd and KEC International could be in limelight for the expected turnround

Obama, Modi to boost bilateral business ties

Obama, Modi to boost bilateral business ties

Rediff.com25 Jan 2015

Trade and economic issues, including visa, totalisation pact and impediments hampering investments, are likely to figure at Monday's US-India CEO Forum meeting, which will be jointly addressed by visiting US President Barack Obama and Prime Minister Narendra Modi.

'All my stocks are crashing. Hold them?'

'All my stocks are crashing. Hold them?'

Rediff.com3 Mar 2022

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

Expert advice: Avoid these stocks and IPOs

Expert advice: Avoid these stocks and IPOs

Rediff.com1 Aug 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Making losses in stocks? Here's help

Making losses in stocks? Here's help

Rediff.com21 Sep 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries

Markets at day's low; PSU banks shine

Markets at day's low; PSU banks shine

Rediff.com6 Jun 2016

Markets at day's low; PSU banks shine.

ASK AJIT: Stocks To Buy, Sell, Hold

ASK AJIT: Stocks To Buy, Sell, Hold

Rediff.com24 Jan 2022

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

AIIMS chief warns against going for CT scan in mild COVID cases

AIIMS chief warns against going for CT scan in mild COVID cases

Rediff.com3 May 2021

"One CT scan is equivalent to 300 to 400 chest x-rays. According to data, repeated CT scans in younger age groups increase the risk of cancer in later life. Exposing yourself to radiation again and again may cause damage. So, there is no point in doing CT scan in mild COVID-19 if the oxygen saturation is normal," Guleria said.

Sensex ends 146 points higher; RIL, HUL put up a good show

Sensex ends 146 points higher; RIL, HUL put up a good show

Rediff.com17 Jun 2015

Sensex ends in green, bluechips in spotlight.

Markets end flat amid volatility; Infosys up 3%

Markets end flat amid volatility; Infosys up 3%

Rediff.com27 Mar 2015

The 30-share Sensex ended up 1 point at 27,459 and the 50-share Nifty ended down 1 point at 8,341.

Stocks to build a long-term portfolio

Stocks to build a long-term portfolio

Rediff.com26 Aug 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

'Covid or not, show must go on'

'Covid or not, show must go on'

Rediff.com19 Apr 2021

'Post-Covid world will be different from the pre-Covid world.'

9 Heart Symptoms You Shouldn't Ignore

9 Heart Symptoms You Shouldn't Ignore

Rediff.com6 Jul 2022

The secret to a healthy heart lies in living a stress-free, well-balanced lifestyle combined with regular physical activity and a good night's sleep, suggests cardiologist Dr Talha Meeran.

Holding too many stocks in your portfolio?

Holding too many stocks in your portfolio?

Rediff.com20 Oct 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

First-time investor: 'I can afford only low-price stocks'

First-time investor: 'I can afford only low-price stocks'

Rediff.com12 Jan 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

What Nehru would have made of the Burari deaths?

What Nehru would have made of the Burari deaths?

Rediff.com9 Jul 2018

'It isn't likely that he would have observed a 'strategic silence' on a sensitive and controversial issue, as is done today by the powers-that-be lest an observation lets the cat out of the bag about the ruling dispensation's mindset,' says Amulya Ganguli.

Facebook's Hate Content Crisis is Ajit Mohan's biggest headache

Facebook's Hate Content Crisis is Ajit Mohan's biggest headache

Rediff.com28 Sep 2020

'The reality is no one, including some of the names that have shown up in the last few weeks, have any unilateral decision-making power in this,' Facebook India MD Ajit Mohan tells Peerzada Abrar.

Don't mock India's scientific past!

Don't mock India's scientific past!

Rediff.com27 Feb 2020

It is important to approach the belief of people in ancient India's achievements with a sense of proportion, balance and empathy, argues B S Raghavan, the distinguished civil servant.

Should you accumulate this stock for 15-20 years?

Should you accumulate this stock for 15-20 years?

Rediff.com4 Dec 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Hydroxychloroquine can be fatal: Experts

Hydroxychloroquine can be fatal: Experts

Rediff.com6 May 2020

As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.

Stocks you must buy, hold or exit

Stocks you must buy, hold or exit

Rediff.com25 Aug 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries:

Sensex jumps 263 points after Ukraine fears recede

Sensex jumps 263 points after Ukraine fears recede

Rediff.com4 Mar 2014

Markets rebound with financials leading the gains on hopes of a peaceful solution to the turmoil in Ukraine

Markets end flat amid rangebound trade; Midcaps outperform

Markets end flat amid rangebound trade; Midcaps outperform

Rediff.com29 Dec 2015

BSE Midcap index outperformed the benchmark indices to end with 0.4% gains.

Stocks that offered highest returns in Samvat 2071

Stocks that offered highest returns in Samvat 2071

Rediff.com6 Nov 2015

The rally in most of these stocks is partly attributed to impressive financial performance.

Why are India's tycoons selling out?

Why are India's tycoons selling out?

Rediff.com21 Jun 2019

Ballooning debt forces more and more Indian promoters to sell out to global majors and PE players.

Sensex ends below 27,000; ITC, ICICI Bank dip 2%

Sensex ends below 27,000; ITC, ICICI Bank dip 2%

Rediff.com7 Jan 2015

The 30-share Sensex ended 79 points lower at 26,909 and the 50-share Nifty closed 25 points lower at 8,102.

Wipro Q1 profit rises 29.5% to Rs 2,103 cr

Wipro Q1 profit rises 29.5% to Rs 2,103 cr

Rediff.com24 Jul 2014

The Bangalore-headquartered firm had posted a net profit of Rs 1,623.3 crore (Rs 16.23 billion) in the year-ago period, it said in a BSE filing.